Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
DLL3 – A Breakthrough Target for Small Cell Lung Cancer Therapy-DIMA ...
Investigational DLL3 & T-Cell Engager Technology for SCLC | DLL3 ...
DLL3 Gene - GeneCards | DLL3 Protein | DLL3 Antibody
Localization of chimeric DLL1 and DLL3 proteins. (A) Schematic ...
Dll3 Protein Atlas at Bryan Riggs blog
Structure of the Notch ligands. Mammalian Notch ligands are single-pass ...
Human DLL3 Protein, His Tag (MALS verified) | ACROBiosystems
DLL3 regulates Notch signaling in small cell lung cancer: iScience
Human DLL3 Protein, hFc Tag-DLL3重组蛋白（C-Human Fc Tag）-缔码生物
Expression and survival analysis of DLL3. (A-C) IHC staining of DLL3 in ...
DLL3 Is a Prognostic and Potentially Predictive Biomarker for ...
Henlius’ DLL3 × CD3 × CD28 Tri-specific TCE: An Integration of ...
Cynomolgus DLL3 (27-488) Protein, His Tag, low endotoxin | ACROBiosystems
Biotinylated Human DLL3 Protein (DLL-HM403B) | KACTUS
DLL3 expression in normal and tumor tissue. DLL3 protein expression via ...
DLL3 (delta-like protein 3) expression correlates with stromal ...
Impact of DLL3 Expression as Prognostic Factor in Extensive Stage of ...
Anti-Human DLL3 Monoclonal Antibody – Humimmu
Representative images of DLL3 protein in small-cell lung cancer (x400 ...
Copy number alteration of DLL3 in a subset of pancreatic cancer cell ...
Dll3 does not activate N signaling in trans. (A) Cell surface ...
DLL3 ADC峰回路转，SCLC治疗突破有望
ACS Fall 2025: 13 First-Time Drug Structure Reveals
POLYMORPHISMS IN THE DLL3 CODING SEQUENCE | Download Table
DLL3 | ACROBiosystems
US20170037130A1 - Antibody constructs for dll3 and cd3 - Google Patents
DLL3 expressions in various cancer cell lines. (a) Examination of DLL3 ...
Biotinylated Human DLL3 Protein (Primary Amine Labeling) (DLL-HM103B)
Human DLL3 Protein (DLL-HM103) | KACTUS
Cynomolgus DLL3 Protein, His Tag (MALS verified) | ACROBiosystems
(PDF) Impact of DLL3 Expression as Prognostic Factor in Extensive Stage ...
Immunohistochemistry of DLL3. The cutoff value was set at 1% for DLL3 ...
DLL3 Antibodies: Novus Biologicals
RCSB PDB - AF_AFO88671F1: Computed structure model of Delta-like protein 3
Wild type DLL3 but not DLL3-S286A,T403V affects the subcellular ...
Invitrogen DLL3 Polyclonal Antibody 100 μg; Unconjugated:Antibodies ...
Assessment of DLL3 and CD3 Expression in Pediatric Tumor FFPE Samples ...
Dll3 expression in T-cell development. (a) Real time PCR expression of ...
Lfng and Dll3 cooperate to modulate protein interactions in cis and ...
Breakout Tumor Target: DLL3 | Roxann Guerrette
Exploring the expression of DLL3 in gastroenteropancreatic ...
聚焦 DLL3 靶点，有望重塑 SCLC 治疗新格局 - 知乎
Targeting DLL3: Innovative Strategies for Tumor Treatment
Blog - DIMA Biotechnology
熙宁生物 | 精翰生物 创新型CRO
Biochemistry of Notch ligands and Notch receptors There are five Notch ...
Taking a Bite Out of Small Cell Lung Cancer By Leveraging Precision ...
DLL3：肺癌治疗新希望与肿瘤研究新热点|DLL|肿瘤|表达|Notch|治疗|-健康界
Delta‐like ligand 3: A promising target against small cell lung cancer ...
Anti-DLL3 ADC - Creative Biolabs
DLL3: Emerging Target in Tumor Therapy Treatment Strategies | KACTUS
Advances in DLL3-targeted therapies for small cell lung cancer ...
靶向DLL3的多特异性抗原结合分子及其用途的制作方法
Analysis of Dll1-Dll3 chimeric ligands. (A) Schematic overview of ...
Frontiers | Advances in DLL3-targeted therapies for small cell lung ...
Mechanism of Action (MOA) | IMDELLTRA® (tarlatamab-dlle) HCP
包含δ样配体3（DLL3）抗原结合结构域的蛋白质及其用途的制作方法
【最强组合】肺癌治疗热门靶点——DLL3 & Notch - 自主发布 - 生物在线 Lab-on-Web
Combined DLL3-targeted bispecific antibody with PD-1 inhibition is ...
1.7亿美元首付：第一三共从默沙东引进一款DLL3/CD3双抗_财富号_东方财富网
靶向DLL3，安进/百济神州递交双特异性T细胞结合器临床申请 3月15日，中国国家药监局药品审评中心（CDE）官网公示， 安进 （Amgen ...
肺和肺外神经内分泌肿瘤中的 Delta 样配体 3 （DLL3） 景观,npj Precision Oncology - X-MOL
DLL3: A New Molecular Target in Cancer - Cusabio
DLL3靶点介绍及药物研究进展-缔码生物
Structural basis for Notch1 engagement of Delta-like 4 | Science
Pharmacokinetics and pharmacodynamics of Tarlatamab, DLL3-Targeted FDA ...
DLL3：多赛道进击小细胞肺癌 DLL3概述Delta样配体3 (Delta-Like Ligand 3, DLL3)是Notch配体家族的 ...
Targeting the DLL/Notch Signaling Pathway in Cancer: Challenges and ...
Double immunofluorescence staining of delta‐like 3 (DLL3) and CHGA in ...
研究报告 | 靶向DLL3药物在研现状 DLL3靶点介绍DLL3是一种高度肿瘤选择性的细胞表面靶点，主要表达于神经或者神经内分泌肿瘤，包括小 ...
Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary ...
The expression levels of delta‐like 3 (DLL3) in... | Download ...
Novel mutations in DLL3, a somitogenesis gene encoding a ligand for the ...
勃林格殷格翰小细胞肺癌新药DLL3/CD3双抗II期临床试验在中国获批
DLL3靶向三特异性蛋白及其使用方法与流程
Drug - ETN029: A DLL3-Targeted Peptide Theranostic for Solid Tumors ...
记住所有FDA生物药 | DLL3×CD3双抗 | Tarlatamab 塔拉塔单抗 | 广泛期小细胞肺癌 - 知乎
The pattern of delta‐like 3 (DLL3) expression in the gastrointestinal ...
The morphological features of delta‐like 3 (DLL3) expression in GI‐NEC ...
针对小细胞肺癌靶向DLL3的新疗法-MedSci.cn
Frontiers | Identification of DLL3-related genes affecting the ...
Anti-DLL3 Therapeutic Programs in Oncology – 2025 Database
Next-generation anti-DLL3 radiopharmaceuticals targeting high-grade ...
【最强组合】肺癌治疗热门靶点——DLL3 & Notch - 知乎
Emerging therapies targeting the delta-like ligand 3 (DLL3) in small ...
想关注一下DLL3为小细胞肺癌的新型靶点问题的答案_行行查_行业研究数据库
The Role of DLLs in Cancer | OTT | Dove Medical Press
2023 WCLC | 小细胞肺癌的探索：DLL3靶向药物，B7-H3 ADC 小细胞肺癌（SCLC）约占肺癌的14%，且预后不良，广泛期患者 ...
DLL3：肺癌治疗新希望与肿瘤研究新热点
DLL3：下一个ADC的明星靶点？
Lung Cancer Biomarkers | Delta-like Ligand 3 (DLL3) | ACROBiosystems
Recombinant Human Delta-like protein 3 (DLL3), (Active)- CUSABIO
研发 | 一文了解DLL3研究进展-世展网
Targets and biomarkers for targeted therapy. DLL3, delta-like protein ...
Delta-like Ligand 3 (DLL3) in Targeted Cancer Therapy
Access our 2025 Database of anti-DLL3 Therapeutic Programmes in ...
【药海听涛】传奇的DLL3，还是DLL3的传奇？ 年底忙于俗务，连看点颇多的ESMO都来不及认真跟进，只看了一些摘要总结就有印象Amgen和 ...
Delta-like protein 3 expression and therapeutic targeting in ...
MA17.13 DLL3-targeted CAR-T Therapy of Small Cell Lung Cancer Utilizing ...
